Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.3 USD | -10.51% |
|
-16.36% | -67.79% |
Evolution of the average Target Price on NovaBay Pharmaceuticals, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering NovaBay Pharmaceuticals, Inc.
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- NBY Stock
- Consensus NovaBay Pharmaceuticals, Inc.